Deborah B Doroshow

Deborah B Doroshow is an Associate Professor of Medicine at the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai. She practices clinically in both the Early Phase Trials Unit and the Center for Thoracic Oncology, specializing in lung cancer treatment and novel agent trials. Her dual expertise spans oncology and the history of medicine.

• MD from Harvard Medical School
• PhD in History from Yale University
• Residency in Internal Medicine at Yale-New Haven Hospital
• Fellowship in Hematology & Medical Oncology at Yale Cancer Center

Dr. Doroshow's research integrates cancer biology with historical perspectives on patient care. She investigates targeted therapies for DNA damage repair mechanisms and strategies to enhance participant experiences in early phase clinical trials. Her scholarship also examines the sociocultural dimensions of illness and treatment through the lens of medical history.

She has received multiple honors including the Solomon Silver Award (2022) and ASCO Career Development Award (2021), with a notable contribution to medical history through her book Emotionally Disturbed: A History of Caring for America's Troubled Children (University of Chicago Press, 2019).

• Solomon Silver Award in Clinical Medicine, 2022
• ASCO Career Development Award & Young Investigator Award
• Robert A. Winn Diversity in Clinical Trials Award
• Faculty Teaching Award
• Jack D. Pressman-Burroughs Wellcome Fund Career Development Award

Dr. Doroshow maintains professional relationships with pharmaceutical companies including Bristol-Myers Squibb, Boehringer Ingelheim, Takeda, and Bayer AG for consulting and data safety monitoring board roles. Her clinical practice and research remain based at Mount Sinai's Annenberg Building in New York.